Penumbra Share Holder Equity 2014-2023 | PEN
Penumbra share holder equity from 2014 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
- Penumbra share holder equity for the quarter ending December 31, 2023 was $1.179B, a 18.03% increase year-over-year.
- Penumbra share holder equity for 2023 was $1.179B, a 18.03% increase from 2022.
- Penumbra share holder equity for 2022 was $0.999B, a 4.71% increase from 2021.
- Penumbra share holder equity for 2021 was $0.954B, a 49.57% increase from 2020.
| Penumbra Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2023 | $1,179 |
| 2022 | $999 |
| 2021 | $954 |
| 2020 | $638 |
| 2019 | $486 |
| 2018 | $422 |
| 2017 | $400 |
| 2016 | $267 |
| 2015 | $233 |
| 2014 | $99 |
| 2013 | $48 |
| Penumbra Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2023-12-31 | $1,179 |
| 2023-09-30 | $1,104 |
| 2023-06-30 | $1,067 |
| 2023-03-31 | $1,024 |
| 2022-12-31 | $999 |
| 2022-09-30 | $974 |
| 2022-06-30 | $970 |
| 2022-03-31 | $959 |
| 2021-12-31 | $954 |
| 2021-09-30 | $685 |
| 2021-06-30 | $673 |
| 2021-03-31 | $650 |
| 2020-12-31 | $638 |
| 2020-09-30 | $620 |
| 2020-06-30 | $623 |
| 2020-03-31 | $488 |
| 2019-12-31 | $486 |
| 2019-09-30 | $467 |
| 2019-06-30 | $454 |
| 2019-03-31 | $437 |
| 2018-12-31 | $422 |
| 2018-09-30 | $409 |
| 2018-06-30 | $425 |
| 2018-03-31 | $415 |
| 2017-12-31 | $400 |
| 2017-09-30 | $384 |
| 2017-06-30 | $373 |
| 2017-03-31 | $373 |
| 2016-12-31 | $267 |
| 2016-09-30 | $254 |
| 2016-06-30 | $248 |
| 2016-03-31 | $238 |
| 2015-12-31 | $233 |
| 2015-09-30 | $229 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | |
| 2014-09-30 | $0 |
| 2013-12-31 | $48 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.083B | $1.059B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $218.485B | 26.48 |
| Intuitive Surgical (ISRG) | United States | $135.271B | 81.49 |
| Edwards Lifesciences (EW) | United States | $51.372B | 33.43 |
| DexCom (DXCM) | United States | $51.051B | 77.33 |
| IQVIA Holdings (IQV) | United States | $40.698B | 23.61 |
| IDEXX Laboratories (IDXX) | United States | $39.691B | 46.53 |
| Alcon (ALC) | Switzerland | $39.236B | 28.93 |
| STERIS (STE) | Ireland | $20.536B | 24.31 |
| Waters (WAT) | United States | $19.053B | 27.34 |
| Hologic (HOLX) | United States | $17.966B | 19.98 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.387B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.392B | 85.37 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.306B | 15.20 |
| Sysmex ADR (SSMXY) | Japan | $10.920B | 34.24 |
| Teleflex (TFX) | United States | $9.562B | 14.88 |
| Masimo (MASI) | United States | $7.249B | 40.65 |
| Globus Medical (GMED) | United States | $7.033B | 22.30 |
| Glaukos (GKOS) | United States | $5.346B | 0.00 |
| TransMedics (TMDX) | United States | $4.216B | 399.97 |
| Integer Holdings (ITGR) | United States | $3.728B | 22.52 |
| LivaNova (LIVN) | United Kingdom | $3.474B | 20.63 |
| PROCEPT BioRobotics (PRCT) | United States | $3.307B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.888B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.712B | 18.60 |
| Nihon Kohden (NHNKY) | Japan | $2.490B | 21.06 |
| Inari Medical (NARI) | United States | $2.444B | 0.00 |
| RxSight (RXST) | United States | $2.281B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.271B | 9.32 |
| Alphatec Holdings (ATEC) | United States | $1.908B | 0.00 |
| Veracyte (VCYT) | United States | $1.556B | 0.00 |
| OPKO Health (OPK) | United States | $0.906B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.903B | 17.57 |
| Paragon 28 (FNA) | United States | $0.873B | 0.00 |
| Artivion (AORT) | United States | $0.862B | 99.67 |
| Silk Road Medical (SILK) | United States | $0.800B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.781B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.679B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.623B | 21.15 |
| SiBone (SIBN) | United States | $0.585B | 0.00 |
| IRadimed (IRMD) | United States | $0.566B | 31.70 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.509B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.498B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.432B | 0.00 |
| Nevro (NVRO) | United States | $0.414B | 0.00 |
| NeuroPace (NPCE) | United States | $0.392B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.339B | 11.42 |
| Sight Sciences (SGHT) | United States | $0.295B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.265B | 0.00 |
| AxoGen (AXGN) | United States | $0.253B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.251B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.208B | 0.00 |
| CVRx (CVRX) | United States | $0.199B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.190B | 10.23 |
| 908 Devices (MASS) | United States | $0.186B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.168B | 0.00 |
| Accuray (ARAY) | United States | $0.161B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.159B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.154B | 0.00 |
| Neuronetics (STIM) | United States | $0.114B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.106B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
| Envoy Medical (COCH) | United States | $0.085B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.070B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.061B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.060B | 121.67 |
| SEP Acquisition (SEPA) | United States | $0.059B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.058B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| InspireMD (NSPR) | Israel | $0.047B | 0.00 |
| DarioHealth (DRIO) | United States | $0.047B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.041B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.040B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.038B | 0.00 |
| LENSAR (LNSR) | United States | $0.037B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.037B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.026B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.024B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.021B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| PAVmed (PAVM) | United States | $0.020B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.019B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |